Tirasemtiv
- Generic Name
- Tirasemtiv
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H14N4O
- CAS Number
- 1005491-05-3
- Unique Ingredient Identifier
- G8WSM7R635
- Background
Tirasemtiv has been used in trials studying the treatment of Myasthenia Gravis, Intermittent Claudication, and Amyotrophic Lateral Sclerosis.
- Associated Conditions
- -
- Associated Therapies
- -
A Study for Patients Who Completed VITALITY-ALS (CY 4031)
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2021-06-15
- Lead Sponsor
- Cytokinetics
- Target Recruit Count
- 280
- Registration Number
- NCT02936635
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Stanford Hospital and Clinics, Stanford, California, United States
🇺🇸The Emory Clinic, Atlanta, Georgia, United States
Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Cytokinetics
- Target Recruit Count
- 744
- Registration Number
- NCT02496767
- Locations
- 🇺🇸
West Virginia University Department of Neurology, Morgantown, West Virginia, United States
🇨🇦CHU de Quebec - Universite Laval Hopital de l'Enfant-Jesus, Quebec, Canada
🇺🇸Georgia Regents University, Augusta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath